부데소니드(Budesonide) 시장 규모, 점유율 및 성장 분석 : 제형별, 적응증별, 유통경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Budesonide Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.67 Billion in 2025 to USD 4.22 Billion by 2033, growing at a CAGR of 5.91% during the forecast period (2026-2033).

The global budesonide market is experiencing robust growth driven by the high prevalence of asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD). This trend is further supported by the increasing adoption of combination inhalation therapies, advancements in drug delivery systems, and a rise in accessible generic formulations. Innovations in inhalation devices and fixed-dose combinations enhance patient compliance and drug efficacy, thereby boosting usage across inhalers, nasal sprays, and oral formulations. Furthermore, investments in respiratory care clinics and improvements in healthcare services are poised to create significant opportunities for budesonide manufacturers. However, challenges such as patent expirations, intense competition from generics, side effects associated with long-term corticosteroid use, and alternative biologic therapies may pose barriers to market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Budesonide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Budesonide Market Segments Analysis

Global budesonide market is segmented by formulation, indication, distribution channel, end-user, and region. Based on formulation, the market is segmented into inhalation (DPI/MDI), nasal spray, oral capsules (enteric-coated), and rectal foam. Based on indication, the market is segmented into Asthma & COPD, Allergic Rhinitis, Crohn's Disease, and Ulcerative Colitis. Based on distribution channel, the market is segmented into retail pharmacies and hospital pharmacies. Based on end-user, the market is segmented into pulmonology and gastroenterology. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Budesonide Market

The global Budesonide market is being significantly driven by the rising preference for direct pulmonary delivery methods that effectively reduce systemic side effects, encouraging healthcare providers to recommend budesonide inhalers for conditions such as asthma and COPD. Enhanced patient compliance is noted with the availability of portable inhalers, which improve treatment outcomes and further incentivize prescribing behaviors among physicians. Additionally, the ease of use associated with outpatient applications makes budesonide versatile across various therapeutic environments, reinforcing its position in respiratory treatments. This trend underlines the growing accessibility and effectiveness of budesonide in managing respiratory diseases.

Restraints in the Global Budesonide Market

The global Budesonide market faces significant constraints due to the rigorous assessments mandated by regulatory agencies regarding the safety and efficacy of inhaled corticosteroid medications. These extensive evaluation processes result in prolonged approval times for new entrants into the market. Consequently, manufacturers are often compelled to invest heavily in the analysis of clinical data and adhere to post-launch study requirements. This leads to a tendency to prioritize less complex drug candidates, thereby delaying the introduction of innovative Budesonide formulations. As a result, the market's response to demand is sluggish, ultimately restraining profit growth and limiting the expected financial returns for investors seeking quicker improvements in revenue.

Market Trends of the Global Budesonide Market

The Global Budesonide market is witnessing a transformative shift towards the adoption of innovative inhaler technologies, characterized by a significant rise in the demand for advanced inhalation devices. This trend is fueled by investment in propellant-free dry powder formulations and smart inhalers equipped with dose-tracking sensors, enhancing drug deposition and patient adherence. The transition towards these cutting-edge delivery platforms is simplifying treatment regimens and improving overall therapeutic efficacy, leading to a growing preference among healthcare professionals for these modern solutions over traditional metered dose inhalers (MDIs). As a result, this evolution is expanding the market potential for budesonide in managing chronic respiratory conditions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Budesonide Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Inhalation (DPI/MDI)
• Nasal Spray
• Oral Capsules (Enteric-Coated)
• Rectal Foam

Global Budesonide Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Asthma & COPD
• Allergic Rhinitis
• Crohn's Disease
• Ulcerative Colitis

Global Budesonide Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies

Global Budesonide Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pulmonology
• Gastroenterology

Global Budesonide Market Size & CAGR (2026-2033)

• North America (Formulation, Indication, Distribution, End-User)
  • US
  • Canada
• Europe (Formulation, Indication, Distribution, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Formulation, Indication, Distribution, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Formulation, Indication, Distribution, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Formulation, Indication, Distribution, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AstraZeneca (Pulmicort, Symbicort)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmo Pharmaceuticals (Uceris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salix Pharmaceuticals (Bausch)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tillotts Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Falk Pharma GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santarus (Bausch)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apotex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz (Novartis)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations